Tennessee Gadolinium Lawsuit Lawyer
If you or someone you love had a magnetic resonance imaging (MRI) or a magnetic resonance angiography (MRA) scan and you suffered an injury, you could be eligible to file a gadolinium lawsuit. Gadolinium-based contrast agents (GBCAs) are used in medical scans and medical imaging tests, but they can cause gadolinium toxicity in patients.
It is critical to learn more about the dangers of GBCAs and to speak with a Tennessee gadolinium lawsuit lawyer as soon as possible to discuss your options for seeking financial compensation. At Fox Farley Willis & Burnette, we have spent years assisting injury victims and their families. One of the dedicated lawyers at our firm can talk with you today about your case.
What is Gadolinium?
Gadolinium is a metal, and gadolinium-based contrast agents (GCBAs) are used as contrast dyes in patient medical scans. Typically, GCBAs are given to patients through an injection prior to a medical imaging procedure. According to the U.S. Food and Drug Administration (FDA), GBCAs are “intravenous drugs used in diagnostic imaging procedures to enhance the quality of magnetic resonance imaging or magnetic resonance angiography.” Magnetic resonance imaging, or MRI, is a procedure that healthcare providers order to see “images of the internal structures of the body.” These scans rely on magnetic fields and radio waves to produce images. GBCAs help to improve the image quality.
FDA Warnings About Gadolinium and GCBAs
Since 2017, the FDA has warned that gadolinium and GCBAs are retained within a patient’s body after a medical imaging procedure, and that this rare earth metal can cause harm in patients.
The FDA warning indicates that GCBAs can “remain in patients’ bodies, including the brain, for months to years after receiving these drugs.”
The FDA specifically warns anyone who is pregnant, anyone with kidney problems, and anyone who has recently received a GCBA injection to speak with a healthcare provider about the risks.
Injuries Linked to Gadolinium and GCBAs in Tennessee
What type of harm is caused by gadolinium and GCBAs? In general, GCBAs can pose a risk of kidney damage, and some of the following conditions have been linked to gadolinium use in medical imaging:
- Gadolinium storage condition;
- Gadolinium deposition disease;
- Nephrogenic systemic fibrosis; and
- Gadolinium toxicity.
According to the American Journal of Roentgenology, each of these conditions can be linked to renal problems and, in some cases, renal failure.
Seek Advice from a Tennessee Dangerous Drugs Lawyer
Gadolinium can be extremely dangerous, both in patients with no history of renal disease and in patients with a history of kidney problems. Although the FDA has issued warnings about the use of GCBAs, patients continue to receive injections prior to undergoing medical imaging procedures.
If you or someone you love developed kidney problems after having an MRI or MRA scan, it is essential to seek advice from a Tennessee dangerous drugs attorney about your options for seeking financial compensation. Many injured patients have already filed gadolinium claims, and one of the attorneys at our firm can discuss your options for filing a gadolinium lawsuit. Contact Fox Farley Willis & Burnette to learn more about how we can help.